TWO · Healthcare

Advagene Biopharma Co. Ltd. (6709)

Biotechnology

Advagene Biopharma Co. Ltd. (6709) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6709

P/E ratio

18.00

Advagene Biopharma Co. Ltd. (6709) — FAQ

What is 6709's P/E ratio?

The price-to-earnings (P/E) ratio for Advagene Biopharma Co. Ltd. (6709) is 18.00 (data as of 2026-03-23).

Does Advagene Biopharma Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Advagene Biopharma Co. Ltd. (6709). Check the MyAverix Finance app for the latest dividend data.

What sector is Advagene Biopharma Co. Ltd. in?

Advagene Biopharma Co. Ltd. (6709) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6709 listed on?

6709 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)